Member access

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  MEDIAN TECHNO    ALMDT   FR0011049824

MEDIAN TECHNO (ALMDT)

8
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

MEDIANTECHNOLOGIES : MEDIAN Technologies and CANON will introduce the LMS solutions at ITEM, April 13-15, 2012, Yokohama, Japan.

04/10/2012 | 03:52am US/Eastern
Recommend:
0

This joint presentation results from the strategic agreement signed between the two entities in July, 2011.

MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, announced today it will demonstrate its Lesion Management Solutions -LMS- clinical application portfolio together with Canon at ITEM, April 13-15, 2012 in Yokohama, Japan.

This joint presentation results from the strategic partnership agreement signed between Canon Inc and MEDIAN Technologies in July, 2011, with three major objectives: 

  • To develop new  Computer-Aided Diagnosis/Detection (CAD) products and services,
  • To make these innovative solutions available to hospitals and biopharmaceutical companies through a cloud-based Software as a Service (SaaS) offering,
  • To establish major clinical partnerships in Japan and Asia in particular to validate new imaging solutions developed through the partnership.

"We have been working very closely with CANON Inc. since the signature of our long-term partnership", said Gerard Milhiet, MEDIAN Executive Vice President and co-founder."We are thrilled to support CANON in exploring new opportunities in the region by leveraging existing LMS applications as well as upcoming co-developed LMS solutions in the context of oncology clinical routine and clinical trials, healthcare IT solutions, and lung cancer screening".

The International Technical Exhibition of Medical Imaging (ITEM) is an academic exhibition organized as a part of JRC 2012 by the Japan Industries Association of Radiological Systems (JIRA). This annual exhibition covers a wide range of medical diagnostic imaging devices with related appliances.

About LMS (Lesion Management Solutions)

MEDIAN Lesion Management Solutions detect, evaluate and follow-up lesions identified in computed tomography (CT) scans. The LMS perform a number of measurements automatically (such as lesion dimensions, volume and density); these parameters are used in both routine clinical practice and during clinical trials to evaluate patient responses to cancer therapies.

LMS are adaptable and compatible with all CT scanners. They can be integrated into heterogeneous IT environments and easily installed on sites with very diverse equipment and software configurations. MEDIAN LMS are provided as "Software as A Service"; they are web-based, fully distributed and available anywhere in the world.

About MEDIAN Technologies

MEDIAN Technologies provides advanced imaging solutions for diagnosing and monitoring cancer patients in clinical trials and in routine clinical practice.  MEDIAN collaborates with institutes at the cutting edge of medical imaging, including the French National Institute for Computer Science and Control (INRIA), the University of Chicago, and the Swiss Federal Institute of Technology in Lausanne, Switzerland (EPFL). 

MEDIAN is present in the market through direct and indirect sales of its LMS solutions and through alliances with specialist cancer centers in Europe and the USA.  MEDIAN has a strategic partnership with Canon, for the development of new technologies, and with Quintiles, to offer integrated imaging services for clinical trials to customers worldwide.

Based in Sophia Antipolis, France, MEDIAN was founded in 2002 by Fredrik Brag (Current CEO), Gérard Milhiet, and Arnaud Butzbach. The company has a staff of 40, over half of whom work in R&D, and has a US-based subsidiary.

Contacts

MEDIAN Technologies Press - Alizé RP

Fredrik Brag, CEO
+33 492 90 65 82

Caroline Carmagnol
+33 6 64 18 99 59
+33 1 42 68 86 43

Anne-Sophie Cosquéric
+33 1 42 68 68 41


distributed by
Recommend :
0
React to this article
Latest news on MEDIAN TECHNO
04/08 MEDIAN TECHNO : ogies : Announces €422K Phase II Project Award
03/22 MEDIAN TECHNO : ogies Enters into EUR700K Pact with a Top 5 Pharmaceutical Compa..
03/17 MEDIAN TECHNO : ogies : Signs a Sales Contract with the University Hospital of P..
03/16 MEDIAN TECHNO : ogies Enters into EUR700K Agreement with a Top 5 Pharmaceutical ..
03/13 MEDIAN TECHNO : ogies Signs a €700K Contract with a Top Five Pharmaceutical Comp..
03/12 MEDIAN TECHNO : MEDIAN Technologies Signs a ?700K Contract with a Top Five Pharm..
03/05 MEDIAN TECHNO : MEDIAN Technologies to Present Results of Three Studies at the 2..
01/29 MEDIAN TECHNO : MEDIAN Technologies Announces ?639K Phase III Project Award
01/13 MEDIAN TECHNO : United States : 384K contract signed by Median with San Francisc..
01/09 MEDIAN TECHNO : MEDIAN Technologies Signs a ?384K Contract with a San Francisco-..
Advertisement
Chart
Duration : Period :
MEDIAN TECHNO Technical Analysis Chart | ALMDT | FR0011049824 | 4-Traders
Income Statement Evolution
MEDIAN TECHNO : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF